Page last updated: 2024-12-07

nip 121

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

NIP 121: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122027
SCHEMBL ID4266855
MeSH IDM0191654

Synonyms (15)

Synonym
7,8-dihydro-6,6-dimethyl-7-hydroxy-8-(2-oxo-piperidin-1-yl)-6h-pyrano(2,3)benz-2,1,3-oxadiazole
nip-121
2-piperidinone, 1-(7,8-dihydro-7-hydroxy-6,6-dimethyl-6h-pyrano(2,3-f)-2,1,3-benzoxadiazol-8-yl)-, trans-(+)-
nip 121
1-[(7r,8s)-7-hydroxy-6,6-dimethyl-7,8-dihydropyrano[2,3-f][2,1,3]benzoxadiazol-8-yl]piperidin-2-one
7dba214y6g ,
unii-7dba214y6g
135244-62-1
2-piperidinone, 1-((7r,8s)-7,8-dihydro-7-hydroxy-6,6-dimethyl-6h-pyrano(2,3-f)-2,1,3-benzoxadiazol-8-yl)-, rel-(+)-
SCHEMBL4266855
nip 1
1-[(12r,13s)-12-hydroxy-11,11-dimethyl-5,10-dioxa-4,6-diazatricyclo[7.4.0.0^{3,7}]trideca-1,3,6,8-tetraen-13-yl]piperidin-2-one
1-(7-hydroxy-6,6-dimethyl-7,8-dihydro-6h-pyrano[2,3-f][2,1,3]benzoxadiazol-8-yl)piperidin-2-one
DTXSID00928912
Q27268109
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's20 (95.24)18.2507
2000's1 (4.76)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.36 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]